Tadle, Jhon .

HRN: 28-62-71  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2026
CEFTRIAXONE 1G (VIAL)
02/27/2026
03/05/2026
IV DRIP
1.1gm
Q12
T/C Typhoid Fever
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: